Why Bioguard is essential to stay compliant without stopping production Kumar Jeetendra | March 5, 2026 QA/QC heads face an impossible choice: enforce contamination control and face pushback, or cut corners and risk regulatory fines. Traditional disinfection forces this trade-off; Bioguard doesn’t. That’s majorly because Indian pharmaceutical manufacturers are standing at a critical crossroad. FDA warning letters hold steady at 23 per year [1], contamination violations are up 25% since 2014 …
